Toward a poliovirus-based simian immunodeficiency virus vaccine: correlation between genetic stability and immunogenicity
- PMID: 9311872
- PMCID: PMC192139
- DOI: 10.1128/JVI.71.10.7841-7850.1997
Toward a poliovirus-based simian immunodeficiency virus vaccine: correlation between genetic stability and immunogenicity
Abstract
Recombinant polioviruses expressing foreign antigens may provide a convenient vaccine vector to engender mucosal immunity. Replication-competent chimeric viruses can be constructed by fusing foreign antigenic sequences to several positions within the poliovirus polyprotein. Artificial cleavage sites ensure appropriate proteolytic processing of the recombinant polyprotein, yielding mature and functional viral proteins. To study the effect of the position of insertion, two different recombinant polioviruses were examined. A small amino-terminus insertion delayed virus maturation and produced a thermosensitive particle. In contrast, insertion at the junction between the P1 and P2 regions yielded a chimeric poliovirus that replicated like the wild type. Eight different chimeras were constructed by inserting simian immunodeficiency virus (SIV) sequences at the P1/P2 junction. All recombinant viruses replicated with near-wild-type efficiency in tissue culture cells and expressed high levels of the SIV antigens. One of the inserted fragments corresponding to gp41 envelope protein was N-glycosylated but was not secreted. Inserted sequences were only partially retained after few rounds of replication in HeLa cells. This problem could be remedied to some extent by altering the sequences flanking the insertion point. Reducing the homology of the direct repeats by 37% decrease the propensity of the recombinant viruses to delete the insert. To determine the immunogenic potential of the recombinants, mice susceptible to poliovirus infection were inoculated intraperitoneally. The antibody titers elicited against Gag p17 depended on the viral doses and the number of inoculations. In addition, recombinants which display higher genetic stability were more effective in inducing an immune response against the SIV antigens, and inoculation with a mix of recombinants carrying different SIV antigens (a cocktail of recombinants) elicited humoral responses against each of the individual SIV sequences.
Similar articles
-
Engineering poliovirus as a vaccine vector for the expression of diverse antigens.Science. 1994 Sep 2;265(5177):1448-51. doi: 10.1126/science.8073288. Science. 1994. PMID: 8073288
-
Expression of foreign proteins by poliovirus polyprotein fusion: analysis of genetic stability reveals rapid deletions and formation of cardioviruslike open reading frames.J Virol. 1998 Jan;72(1):20-31. doi: 10.1128/JVI.72.1.20-31.1998. J Virol. 1998. PMID: 9420196 Free PMC article.
-
Mucosal immunization of cynomolgus macaques with two serotypes of live poliovirus vectors expressing simian immunodeficiency virus antigens: stimulation of humoral, mucosal, and cellular immunity.J Virol. 1999 Nov;73(11):9485-95. doi: 10.1128/JVI.73.11.9485-9495.1999. J Virol. 1999. PMID: 10516057 Free PMC article.
-
Poliovirus vaccine strains as mucosal vaccine vectors and their potential use to develop an AIDS vaccine.Adv Drug Deliv Rev. 2004 Apr 19;56(6):835-52. doi: 10.1016/j.addr.2003.10.042. Adv Drug Deliv Rev. 2004. PMID: 15063593 Review.
-
Human and simian immunodeficiency viruses: virus-receptor interactions.Trends Microbiol. 1993 Dec;1(9):328-33. doi: 10.1016/0966-842x(93)90072-y. Trends Microbiol. 1993. PMID: 8162421 Review.
Cited by
-
Expression and stability of foreign epitopes introduced into 3A nonstructural protein of foot-and-mouth disease virus.PLoS One. 2012;7(7):e41486. doi: 10.1371/journal.pone.0041486. Epub 2012 Jul 27. PLoS One. 2012. PMID: 22848509 Free PMC article.
-
Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors.J Virol. 2001 Aug;75(16):7435-52. doi: 10.1128/JVI.75.16.7435-7452.2001. J Virol. 2001. PMID: 11462016 Free PMC article.
-
Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.J Virol. 2001 Sep;75(17):8187-94. doi: 10.1128/jvi.75.17.8187-8194.2001. J Virol. 2001. PMID: 11483764 Free PMC article.
-
Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines.Cell Host Microbe. 2008 Sep 11;4(3):239-48. doi: 10.1016/j.chom.2008.08.003. Cell Host Microbe. 2008. PMID: 18779050 Free PMC article.
-
Characterization of recombinant hepatitis A virus genomes containing exogenous sequences at the 2A/2B junction.J Virol. 2001 Feb;75(3):1414-26. doi: 10.1128/JVI.75.3.1414-1426.2001. J Virol. 2001. PMID: 11152515 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources